AMPs induce cell death in various cancer cell types, such as urinary bladder cancer (Suttmann et al., 2008), breast cancer (Guzmán-Rodríguez et al., 2016), colorectal cancer (Norouzi et al., 2018), glioblastoma (Chen et al., 2020), non-small-cell lung carcinoma (NSCLC) (Liu et al., 2017), and multiple myeloma (Hilchie et al., 2013a). This evidence concerns the gene ADSL and non-small cell lung carcinoma.